Earnings Call
Aug 5, 2026
Q2 FY2026
EPS Estimate
1.47
EPS Actual
1.66
Post-Earnings Close
$133.26
Earnings Reaction
-20.1%
Insulet's second quarter results were bifurcated: headline numbers came in ahead of expectations, but a material downward revision to full-year U.S. Omnipod guidance, driven by worse-than-anticipated retention and utilization among type 2 diabetes customers, dominated the call and overshadowed an otherwise strong operational performance. Total revenue of $802 million grew 22.7% in constant currency, beating the company's own prior expectations, while adjusted EPS of $1.66 rose 41.5% year-over-year, nearly twice the rate of revenue growth. Adjusted gross margin expanded 320 basis points to 72.9%, reflecting manufacturing productivity gains at Acton and Malaysia, favorable pricing, and volume leverage. Adjusted operating margin reached 19.3%, up 140 basis points. By any conventional measure, this was a strong quarter, but the forward guidance reset is what investors will be focused on.
Report generated on Aug 6, 2026
AI-generated earnings analysis. Not investment advice.
Chief Executive Officer
The quarter's results reflected a combination of company-specific execution and broader sector dynamics, with management addressing several of the key debates that analysts had flagged heading into the print. Guidance commentary pointed to continued momentum in the core segments, while questions on margins and capital allocation drew more nuanced responses from the leadership team over the course of the call.
The quarter's results reflected a combination of company-specific execution and broader sector dynamics, with management addressing several of the key debates that analysts had flagged heading into the print. Guidance commentary pointed to continued momentum in the core segments, while questions on margins and capital allocation drew more nuanced responses from the leadership team over the course of the call.
The quarter's results reflected a combination of company-specific execution and broader sector dynamics, with management addressing several of the key debates that analysts had flagged heading into the print. Guidance commentary pointed to continued momentum in the core segments, while questions on margins and capital allocation drew more nuanced responses from the leadership team over the course of the call.
Read the full PODD analysis
The complete report, with key themes, analyst Q&A summary, notable quotes, and market context — is free with an account. No password, no card.